Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gulnar Hafiz

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
American Journal of Ophthalmology|August 16, 2020
Locus-Level Changes in Macular Sensitivity in Patients with Retinitis Pigmentosa Treated with Oral N-acetylcysteineXiangrong Kong, Gulnar Hafiz, Dagmar Wehling, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 15, 2005
Cataract and barriers to cataract surgery in a US Hispanic population: Proyecto VERAimee Teo Broman, Gulnar Hafiz, Beatriz Muñoz, et al.
Retina (Philadelphia, Pa.)|December 13, 2022
URINARY METABOLOMICS OF CENTRAL SEROUS CHORIORETINOPATHYCatherine B Meyerle, Pin Lyu, Jiang Qian, et al.
Ophthalmology|August 1, 2006
A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
JAMA Ophthalmology|April 2, 2013
Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatmentDiana V Do, Quan D Nguyen, Afsheen A Khwaja, et al.
Journal of Cellular Physiology|February 12, 2014
Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGFJikui Shen, David F Choy, Tsunehiko Yoshida, et al.
Ophthalmology|August 25, 2009
Monitoring ocular drug therapy by analysis of aqueous samplesPeter A Campochiaro, David F Choy, Diana V Do, et al.
The Journal of Clinical Investigation|December 6, 2019
Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trialPeter A Campochiaro, Mustafa Iftikhar, Gulnar Hafiz, et al.
Antioxidants & Redox Signaling|March 31, 2015
Is There Excess Oxidative Stress and Damage in Eyes of Patients with Retinitis Pigmentosa?Peter A Campochiaro, Rupert W Strauss, Lili Lu, et al.
Retina (Philadelphia, Pa.)|January 12, 2010
A randomized, double-masked controlled clinical trial of Sandostatin long-acting release depot in patients with postsurgical cystoid macular edemaSyed Mahmood Ali Shah, Quan Dong Nguyen, Hafsa Syyida Mir, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
American Journal of Ophthalmology|August 16, 2020
Locus-Level Changes in Macular Sensitivity in Patients with Retinitis Pigmentosa Treated with Oral N-acetylcysteineXiangrong Kong, Gulnar Hafiz, Dagmar Wehling, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|September 15, 2005
Cataract and barriers to cataract surgery in a US Hispanic population: Proyecto VERAimee Teo Broman, Gulnar Hafiz, Beatriz Muñoz, et al.
Retina (Philadelphia, Pa.)|December 13, 2022
URINARY METABOLOMICS OF CENTRAL SEROUS CHORIORETINOPATHYCatherine B Meyerle, Pin Lyu, Jiang Qian, et al.
Ophthalmology|August 1, 2006
A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degenerationQuan Dong Nguyen, Syed Mahmood Shah, Gulnar Hafiz, et al.
JAMA Ophthalmology|April 2, 2013
Ranibizumab for edema of the macula in diabetes study: 3-year outcomes and the need for prolonged frequent treatmentDiana V Do, Quan D Nguyen, Afsheen A Khwaja, et al.
Journal of Cellular Physiology|February 12, 2014
Interleukin-18 has antipermeablity and antiangiogenic activities in the eye: reciprocal suppression with VEGFJikui Shen, David F Choy, Tsunehiko Yoshida, et al.
Ophthalmology|August 25, 2009
Monitoring ocular drug therapy by analysis of aqueous samplesPeter A Campochiaro, David F Choy, Diana V Do, et al.
The Journal of Clinical Investigation|December 6, 2019
Oral N-acetylcysteine improves cone function in retinitis pigmentosa patients in phase I trialPeter A Campochiaro, Mustafa Iftikhar, Gulnar Hafiz, et al.
Antioxidants & Redox Signaling|March 31, 2015
Is There Excess Oxidative Stress and Damage in Eyes of Patients with Retinitis Pigmentosa?Peter A Campochiaro, Rupert W Strauss, Lili Lu, et al.
Retina (Philadelphia, Pa.)|January 12, 2010
A randomized, double-masked controlled clinical trial of Sandostatin long-acting release depot in patients with postsurgical cystoid macular edemaSyed Mahmood Ali Shah, Quan Dong Nguyen, Hafsa Syyida Mir, et al.
Pageof 3